Browsing 408 Presentations

Sort By
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6) Educational session

Beyond HER2: Dissecting tumour heterogeneity

Lecture Time
14:50 - 15:10
Presenter
  • Aleix Prat (Barcelona, Spain)
Session Name
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6)
Room
Channel 1
Date
23.05.2020
Time
14:30 - 16:00
Authors
  • Aleix Prat (Barcelona, Spain)
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6) Educational session

Neoadjuvant approach for treatment escalation and de-escalation

Lecture Time
15:10 - 15:30
Presenter
  • Valentina Guarneri (Padova, Italy)
Session Name
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6)
Room
Channel 1
Date
23.05.2020
Time
14:30 - 16:00
Authors
  • Valentina Guarneri (Padova, Italy)
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6) Educational session

A look into the future: Challenges for the regulatory framework

Lecture Time
15:30 - 15:50
Presenter
  • Sibylle Loibl (Neu-Isenburg, Germany)
Session Name
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6)
Room
Channel 1
Date
23.05.2020
Time
14:30 - 16:00
Authors
  • Sibylle Loibl (Neu-Isenburg, Germany)
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6) Educational session

Live Q&A

Lecture Time
15:50 - 16:00
Session Name
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6)
Room
Channel 1
Date
23.05.2020
Time
14:30 - 16:00
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6) Educational session

Introduction

Lecture Time
14:30 - 14:30
Session Name
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6)
Room
Channel 1
Date
23.05.2020
Time
14:30 - 16:00
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6) Educational session

Current standards for HER2+ EBC

Lecture Time
14:30 - 14:50
Presenter
  • Sara M. Tolaney (Boston, MA, United States of America)
Session Name
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6)
Room
Channel 1
Date
23.05.2020
Time
14:30 - 16:00
Authors
  • Sara M. Tolaney (Boston, MA, United States of America)
Closing video (ID 82) Opening/closure

Closure of the meeting

Lecture Time
19:30 - 19:35
Presenter
  • Giuseppe Curigliano (Milan, Italy)
  • Sibylle Loibl (Neu-Isenburg, Germany)
Session Name
Closing video (ID 82)
Room
Channel 1
Date
24.05.2020
Time
19:30 - 19:35
Authors
  • Giuseppe Curigliano (Milan, Italy)
  • Sibylle Loibl (Neu-Isenburg, Germany)

Novel Anti-HER2-Directed ADCs

Presenter
  • Adam M. Brufsky (Pittsburgh, PA, United States of America)

Novel Targeted Therapies for MBC - Tyrosine kinase inhibitors

Presenter
  • Cristina Saura Manich (Barcelona, Spain)

Novel Anti-HER2 Monoclonal Antibody

Presenter
  • Thomas Bachelot (Lyon, France)

Case Discussion: Medical Need for Novel HER2-Directed Options After Failure on Standard-of-Care Treatments

Presenter
  • Thomas Bachelot (Lyon, France)
Collaborative session ESMO ESO: Breast Cancer in young women: From guidelines to clinical practice (ID 18) Special session

Genetic predisposition in the era of multigene panel testing: impact on clinical management

Lecture Time
19:55 - 20:15
Presenter
  • Jennifer K. Litton (Houston, United States of America)
Session Name
Collaborative session ESMO ESO: Breast Cancer in young women: From guidelines to clinical practice (ID 18)
Room
Channel 3
Date
23.05.2020
Time
19:30 - 21:00
Authors
  • Jennifer K. Litton (Houston, United States of America)